Manufacturer record
East West Pharma (India) Pvt. Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
4 batches manufactured by East West Pharma (India) Pvt. Ltd (Uttarakhand) were declared Not of Standard Quality between September 2022 and January 2023. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
4 records linked to East West Pharma (India) Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Neurace (Vitamin A, C, E & Selenium Capsules ) | C00458Mfg 2022-07 · Exp 2023-12 | Assay of Vitamin AAssay | CDL KolkataCDSCO lab | Jan 2023 |
| Thirobal -5 (Carbimazole Tablets I.P. 5 mg) | T-01497Mfg 2021-04 · Exp 2022-09 | Thiamazole and other related substancesRelated substances | CDL KolkataCDSCO lab | Sep 2022 |
| Thirobal -5 (Carbimazole Tablets I.P. 5 mg) | T-02099Mfg 2021-07 · Exp 2022-12 | Thiamazole and other related substancesRelated substances | CDL KolkataCDSCO lab | Sep 2022 |
| Misopres -200 (Misoprostol Tablets I.P. 200 mcg) | T-02095Mfg 2021-07 · Exp 2023-06 | AssayAssay | CDL KolkataCDSCO lab | Sep 2022 |
Batches reported as suspected spurious under this label
CDSCO's spurious-drug alerts list batches that purport to be made by a company but are suspected counterfeits. The labelled manufacturer's reply is shown where CDSCO published it.
| Product | Batch | Reported by | Firm's reply | Alert |
|---|---|---|---|---|
| Trypsin-Chymotrypsin Tablets | 2KU6L055 | FDAL Maharashtra | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. | Jan 2026 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.